LINC00460 was also demonstrated overexpressed in NSCLC and promotes epithelial-mesenchymal transition and cell migration [42], what’s more, as an FRGs-lncRNA, LINC00460 was identified as a predictor and potential therapeutic target for EGFR‐TKI resistance in NSCLC [43]. The gene discussed is LINC00460; the disease is non-small cell lung carcinoma.